These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23990094)

  • 1. [Effects of the MMR vaccination on the epidemiology of mumps in Germany].
    Koch J; Takla A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1305-12. PubMed ID: 23990094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination].
    Siedler A; Hecht J; Rieck T; Tolksdorf K; Hengel H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1313-20. PubMed ID: 23990095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.
    Beleni AI; Borgmann S
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps in Poland in 2012.
    Rogalska J; Paradowska-Stankiewicz I
    Przegl Epidemiol; 2014; 68(2):191-3, 317-8. PubMed ID: 25135497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China.
    Zhou C; Song W; Yin Z; Li S; Gong X; Fang Q; Wang S
    J Immunol Res; 2020; 2020():8130760. PubMed ID: 32300606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mumps in Poland in 2013.
    Korczyńska MR; Rogalska J
    Przegl Epidemiol; 2015; 69(2):209-12, 339-40. PubMed ID: 26233073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mumps--still actual epidemiological problem in Poland].
    Pogorzelska M; Ołdak E; Sulik A
    Przegl Epidemiol; 2005; 59(4):841-9. PubMed ID: 16729425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mumps in Poland in 2003].
    Rosińska M
    Przegl Epidemiol; 2005; 59(2):209-13. PubMed ID: 16190522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mumps in Poland in 2006].
    Stefanoff P; Rogalska J
    Przegl Epidemiol; 2008; 62(2):225-8. PubMed ID: 18807461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience.
    Papania MJ; Wallace GS; Rota PA; Icenogle JP; Fiebelkorn AP; Armstrong GL; Reef SE; Redd SB; Abernathy ES; Barskey AE; Hao L; McLean HQ; Rota JS; Bellini WJ; Seward JF
    JAMA Pediatr; 2014 Feb; 168(2):148-55. PubMed ID: 24311021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mumps epidemiology in Germany 2007-11.
    Takla A; Wichmann O; Klinc C; Hautmann W; Rieck T; Koch J
    Euro Surveill; 2013 Aug; 18(33):20557. PubMed ID: 23968877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current vaccination coverage and immunization gaps of children and adolescents in Germany].
    Reiter S; Poethko-Müller C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Nov; 52(11):1037-44. PubMed ID: 19756337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak.
    Ogbuanu IU; Kutty PK; Hudson JM; Blog D; Abedi GR; Goodell S; Lawler J; McLean HQ; Pollock L; Rausch-Phung E; Schulte C; Valure B; Armstrong GL; Gallagher K
    Pediatrics; 2012 Dec; 130(6):e1567-74. PubMed ID: 23129075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
    Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance of measles in Germany].
    Tischer A; Siedler A; Rasch G
    Gesundheitswesen; 2001 Nov; 63(11):703-9. PubMed ID: 11713702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.